Cargando…

Evoked Potentials and Memory/Cognition Tests Validate Brain Atrophy as Measured by 3T MRI (NeuroQuant) in Cognitively Impaired Patients

To our knowledge, this is the largest study evaluating relationships between 3T Magnetic Resonance Imaging (MRI) and P300 and memory/cognitive tests in the literature. The 3T MRI using NeuroQuant has an increased resolution 15 times that of 1.5T MRI. Utilizing NeuroQuant 3T MRI as a diagnostic tool...

Descripción completa

Detalles Bibliográficos
Autores principales:	Braverman, Eric R., Blum, Kenneth, Hussman, Karl L., Han, David, Dushaj, Kristina, Li, Mona, Marin, Gabriela, Badgaiyan, Rajendra D., Smayda, Richard, Gold, Mark S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526533/ https://www.ncbi.nlm.nih.gov/pubmed/26244349 http://dx.doi.org/10.1371/journal.pone.0133609

Ejemplares similares

Comparison of Automated Brain Volume Measures by NeuroQuant vs. Freesurfer in Patients with Mild Cognitive Impairment: Effect of Slice Thickness
por: Yim, Younghee, et al.
Publicado: (2021)

Updated Review of the Evidence Supporting the Medical and Legal Use of NeuroQuant(®) and NeuroGage(®) in Patients With Traumatic Brain Injury
por: Ross, David E., et al.
Publicado: (2022)

Comparison of Normative Percentiles of Brain Volume Obtained from NeuroQuant(®) vs. DeepBrain(®) in the Korean Population: Correlation with Cranial Shape
Publicado: (2023)

Development and validation of a deep learning-based automatic segmentation model for assessing intracranial volume: comparison with NeuroQuant, FreeSurfer, and SynthSeg
por: Suh, Pae Sun, et al.
Publicado: (2023)

Evoked Potentials and Neuropsychological Tests Validate Positron Emission Topography (PET) Brain Metabolism in Cognitively Impaired Patients
por: Braverman, Eric R., et al.
Publicado: (2013)

Hypothesizing that, A Pro-Dopamine Regulator (KB220Z) Should Optimize, but Not Hyper-Activate the Activity of Trace Amine-Associated Receptor 1 (TAAR-1) and Induce Anti-Craving of Psychostimulants in the Long-Term
por: Blum, Kenneth, et al.
Publicado: (2016)

Pilot clinical observations between food and drug seeking derived from fifty cases attending an eating disorder clinic
por: Beitscher-Campbell, Harriet, et al.
Publicado: (2016)

Pro-Dopamine Regulator – (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS)
por: Blum, Kenneth, et al.
Publicado: (2017)

KB220Z™ a Pro-Dopamine Regulator Associated with the Protracted, Alleviation of Terrifying Lucid Dreams. Can We Infer Neuroplasticity-induced Changes in the Reward Circuit?
por: McLaughlin, Thomas, et al.
Publicado: (2016)

Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape
por: Blum, Kenneth, et al.
Publicado: (2017)

Validation and reliability study of the Turkish version of the Neuroquality of Life (Neuro-QoL)-Stigma Scale for neurological disorders
por: KARŞIDAĞ, Sibel, et al.
Publicado: (2019)

Hypothesizing that a Pro-Dopaminergic Regulator (KB220z(™) Liquid Variant) can Induce “Dopamine Homeostasis” and Provide Adjunctive Detoxification Benefits in Opiate/Opioid Dependence
por: Blum, Kenneth, et al.
Publicado: (2016)

NIDA-Drug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/Religiosity
por: Schoenthaler, Stephen J., et al.
Publicado: (2015)

Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence?
por: Madigan, Margaret A., et al.
Publicado: (2022)

Hypothesizing Balancing Endorphinergic and Glutaminergic Systems to Treat and Prevent Relapse to Reward Deficiency Behaviors: Coupling D-Phenylalanine and N-Acetyl-L-Cysteine (NAC) as a Novel Therapeutic Modality
por: Blum, Kenneth, et al.
Publicado: (2015)

“Pro-dopamine regulation (KB220Z™)” as a long-term therapeutic modality to overcome reduced resting state dopamine tone in opiate/opioid epidemic in America
por: Blum, K, et al.
Publicado: (2016)

Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics
por: Blum, Kenneth, et al.
Publicado: (2015)

Correction: Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics
por: Blum, Kenneth, et al.
Publicado: (2015)

Retraction: Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics
por: Blum, Kenneth, et al.
Publicado: (2015)

Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics
por: Blum, Kenneth, et al.
Publicado: (2015)

Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction
por: Blum, Kenneth, et al.
Publicado: (2015)

Neurobiology of KB220Z-Glutaminergic-Dopaminergic Optimization Complex [GDOC] as a Liquid Nano: Clinical Activation of Brain in a Highly Functional Clinician Improving Focus, Motivation and Overall Sensory Input Following Chronic Intake
por: Duquette, Lucien L, et al.
Publicado: (2016)

Preliminary Hormonal Correlations in Female Patients as a Function of Somatic and Neurological Symptom Clusters: An Exploratory Development of a Multi-Hormonal Map for Bio-Identical Replacement Therapy (MHRT)
por: Braverman, Eric R, et al.
Publicado: (2013)

The jmzQuantML programming interface and validator for the mzQuantML data standard
por: Qi, Da, et al.
Publicado: (2014)

Editorial: Cognitive NeuroIntelligence
por: Song, Yiying, et al.
Publicado: (2021)

Neuro-cognition and social-cognition: application to exercise rehabilitation
por: Kim, Sooyeon
Publicado: (2013)

Menopause Analytical Hormonal Correlate Outcome Study (MAHCOS) and the Association to Brain Electrophysiology (P300) in a Clinical Setting
por: Braverman, Eric R., et al.
Publicado: (2014)

Triqler for MaxQuant: Enhancing Results from MaxQuant by Bayesian Error Propagation and Integration
por: The, Matthew, et al.
Publicado: (2021)

Improvement of long-term memory access with a pro-dopamine regulator in an elderly male: Are we targeting dopamine tone?
por: McLaughlin, Thomas, et al.
Publicado: (2017)

Neurogenetic and Epigenetic Aspects of Cannabinoids
por: Dennen, Catherine A., et al.
Publicado: (2022)

Editorial: Neuro-cognitive Architecture of Numerical Cognition and Its Development
por: Klein, Elise, et al.
Publicado: (2021)

Keeping up with the quants : your guide to understanding and using analytics
por: Davenport, Thomas H. 1954-
Publicado: (2013)

Calvin klein (CK) designer cocktail, new “Speedball” is the “grimm reaper”: Brain dopaminergic surge a potential death sentence
por: Gold, Mark S, et al.
Publicado: (2020)

Opioid and dopamine genes interact to predict precision naltrexone response in alcohol use disorder: Interpretation misfires
por: Blum, Kenneth, et al.
Publicado: (2021)

(Neuro) Peptides, Physical Activity, and Cognition
por: Autio, Juho, et al.
Publicado: (2020)

Cognitive impairment in patients with Neuro‐Sjögren
por: Seeliger, Tabea, et al.
Publicado: (2020)

Music and neuro-cognitive deficits in depression
por: Raghavendra, Prathima A., et al.
Publicado: (2022)

Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z
por: Febo, Marcelo, et al.
Publicado: (2017)

Cognitive Profiles and Atrophy Ratings on MRI in Senior Patients With Mild Cognitive Impairment
por: Flak, Marianne M., et al.
Publicado: (2018)

Enhanced cognitive and perceptual processing: a computational basis for the musician advantage in speech learning
por: Smayda, Kirsten E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mc14n8ml02pg9mvhsns5lkc74k